v3.26.3
Organization and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the unaudited condensed consolidated balance sheets that sum to the total of the same such amounts shown in the unaudited condensed consolidated statements of cash flows as of September 30, 2026 and 2025 (in thousands):

 

 

 

As of September 30,

 

 

 

2026

 

 

2025

 

Cash and cash equivalents

 

$

43,942

 

 

$

40,622

 

Restricted cash

 

 

5,100

 

 

 

10,227

 

Total cash, cash equivalents, and restricted cash shown in the unaudited condensed consolidated statement of cash flows

 

$

49,042

 

 

$

50,849

 

Schedule of Basic and Diluted Net Loss per Share Attributable to Stockholders

Basic and diluted net loss per share attributable to stockholders for the three and nine months ended September 30, 2026 and 2025 are calculated as follows (in thousands, except share and per share data):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(30,687

)

 

$

(32,250

)

 

$

(92,059

)

 

$

(103,941

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Shares used to compute net loss per share, basic and diluted

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

119,763,135

 

 

 

115,105,019

 

 

 

117,481,221

 

 

 

114,742,701

 

Weighted-average pre-funded warrants

 

 

3,893,674

 

 

 

3,893,674

 

 

 

3,893,674

 

 

 

3,893,674

 

Weighted-average common shares outstanding used to
    compute basic and diluted net loss per share

 

 

123,656,809

 

 

 

118,998,693

 

 

 

121,374,895

 

 

 

118,636,375

 

Net loss per share, basic and diluted

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.25

)

 

$

(0.27

)

 

$

(0.76

)

 

$

(0.88

)

Schedule of Anti-Dilutive Securities not Included in Calculation of Net Loss per Common Share

The following outstanding shares of potentially dilutive securities are excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive:

 

 

 

As of September 30,

 

 

 

2026

 

 

2025

 

Convertible preferred stock

 

 

13,775,430

 

 

 

13,775,430

 

Outstanding options to purchase common stock

 

 

16,123,870

 

 

 

12,597,399

 

Outstanding restricted stock units

 

 

6,611,125

 

 

 

6,647,093

 

Total

 

 

36,510,425

 

 

 

33,019,922